Evaluation of HIF-1 inhibitors as anticancer agents (Q28253053)

scientific article

Language	Label	Description	Also known as
English	Evaluation of HIF-1 inhibitors as anticancer agents	scientific article

Statements

instance of

scholarly article

0 references

review article

1 reference

stated in

Europe PubMed Central

title

Evaluation of HIF-1 inhibitors as anticancer agents (English)

0 references

1

Gregg L Semenza

0 references

language of work or name

English

0 references

publication date

October 2007

0 references

published in

Drug Discovery Today

0 references

volume

12

0 references

page(s)

853-9

0 references

issue

19-20

0 references

cites work

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/20459

Hsp90: a novel target for cancer therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1alpha C-terminal activation domain

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Targeting HIF-1 for cancer therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

p53 stabilization and transactivation by a von Hippel-Lindau protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switch

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Laurenditerpenol, a new diterpene from the tropical marine alga Laurenciaintricata that potently inhibits HIF-1 mediated hypoxic signaling in breast tumor cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

HIF-1-mediated activation of telomerase in cervical cancer cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Induction ofID2Expression by Hypoxia-inducible Factor-1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Regulation of DNA repair in hypoxic cancer cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Clinicopathological significance of hypoxia-inducible factor-1alpha expression in human pancreatic carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Bisphenol A, an environmental endocrine-disrupting chemical, inhibits hypoxic response via degradation of hypoxia-inducible factor 1alpha (HIF-1alpha): structural requirement of bisphenol A for degradation of HIF-1alpha

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Schedule-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia: a key regulator of angiogenesis in cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1alpha protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Effects of hypoxia on tumor metabolism

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Regulation of tumor pH and the role of carbonic anhydrase 9.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Baffled by bafilomycin: an anticancer agent that induces hypoxia-inducible factor-1alpha expression.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Metastasis and stem cell pathways

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Development of novel therapeutic strategies that target HIF-1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia and adaptive landscapes in the evolution of carcinogenesis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Endostatin's antiangiogenic signaling network

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1alpha expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Saururus cernuus lignans--potent small molecule inhibitors of hypoxia-inducible factor-1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

GL331 inhibits HIF-1alpha expression in a lung cancer model

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factors and hypoxic cell death in tumour physiology

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT).

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

HIF-1alpha is essential for myeloid cell-mediated inflammation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia, gene expression, and metastasis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1alpha activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia-driven selection of the metastatic phenotype

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia in cancer: significance and impact on clinical outcome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Regulation of E-cadherin expression by VHL and hypoxia-inducible factor.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Design of clinical trials of radiation combined with antiangiogenic therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Genetic evidence for a tumor suppressor role of HIF-2alpha.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.DRUDIS.2007.08.006

Identifiers

DOI

10.1016/J.DRUDIS.2007.08.006

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

711738

Fatcat ID

release_tdccmu5pn5a57do2ggfzcxrt4i

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/tdccmu5pn5a57do2ggfzcxrt4i

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

711738

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

711738

Evaluation of HIF-1 inhibitors as anticancer agents (Q28253053)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Evaluation of HIF-1 inhibitors as anticancer agents (Q28253053)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search